Pharmaceutical science to improve the human condition
Subtitle: winners and finalists for the Prix Galien USA Awards 2013
By: editor-in-chief, Douglas Braaten ; associate editors, David Alvaro, Azra Jaferi
Contributors: New York Academy of Sciences
Series: Annals of the New York Academy of Sciences -- volume 1329; Annals of the New York Academy of Sciences -- v. 1329.
Publisher: published on behalf of the New York Academy of Sciences by Wiley Subscription Services
Published: 2014
Place of publication: Hoboken, NJ
Language: eng
Number of pages: 115
Subjects: Pharmaceutical industry; Awards and Prizes; Pharmacology; Drug Industry; Drug Discovery; Pharmaceutical Technology
Other titles: Winners and finalists for the Prix Galien USA Awards 2013
Notes: Caption title.

Includes bibliographical references.
Table of contents: title: Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death / Rick Sanghera [and three others]; title: Advances in epilepsy treatment : lacosamide pharmacokinetic profile / Willi Cawello [and three others]; title: Development of dalfampridine, a novel pharmacologic approach for treating walking impairment in multiple sclerosis / Andrew R. Blight, Herbert R. Henney III, and Ron Cohen; title: Rotigotine transdermal system : developing continuous dopaminergic delivery to treat Parkinson's disease and restless legs syndrome / Arturo Benitez [and four others]; title: Development of onabotulinumtoxinA for chronic migraine / Scott M. Whitcup [and three others]; title: Development of asparaginase Erwinia chrysanthemi for the treatment of acute lymphoblastic leukemia / Wanda L. Salzer [and four others]; title: Development of apixaban : a novel anticoagulant for prevention of stroke in patients with atrial fibrillation / Michael S. Hanna [and five others]; title: Development of the Trevo ProVue Retriever for intracranial clot removal in acute ischemic stroke / Heather C. Prince [and three others].